Recurrent phlebothromboses and chronic venous leg ulcers: Manifestations of hereditary disorders of hemostasis and of Klinefelter's syndrome. Report of 4 cases and review;Rezidivierende Phlebothrombosen und Ulcera crurum als Manifestationsformen hereditarer Gerinnungsstorungen und des Klinefelter-Syndroms. Diskussion anhand von 4 Fallbeispielen

Hautarzt

Volumn 48, Issue 9, 1997, Pages 634-639

  Ramaker, Jutta ^a   Goerdt, Sergij ^a   Zouboulis, Christos C ^a   Schramm, Wolfgang ^b   Orfanos, Constantin E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

activated protein C resistance; antithrombin III; chronic venous leg ulcers; factor V mutation; Klinefelter's syndrome; phlebothrombosis; postthrombotic syndrome; protein C; protein S

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5; PENTOXIFYLLINE; PHENPROCOUMON; PROTEIN C; PROTEIN S; THIOCTIC ACID;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; HUMAN; KLINEFELTER SYNDROME; LEG ULCER; MALE; MUTATION; VEIN THROMBOSIS;

ADULT; ANTITHROMBIN III DEFICIENCY; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; HUMANS; KLINEFELTER SYNDROME; MALE; POSTPHLEBITIC SYNDROME; PROTEIN S DEFICIENCY; RECEPTORS, CELL SURFACE; THROMBOPHILIA; THROMBOPHLEBITIS; VARICOSE ULCER;

EID: 0030865554     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050636     Document Type: Article

References (32)

1. Andersen KE (1979) Sex chromosomal anomalies: a possible association with leg ulcers. Clin Exp Dermatol 4:223-226
2. Becker KL (1972) Clinical and therapeutic experiences with Klinefelter's syndrome. Fertil Steril 23:568-578
3. Bertina RM, Koelman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
4. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP (1995) Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 74:449-453
5. Bick RL, Pegram M (1994) Syndromes of hypercoagulability and thrombosis: a review. Semin Thromb Haemost 20:109-132
6. Bick RL, Ancypa D (1995) Thrombosis and hemostasis for the clinical laboratory: part II: blood protein defects associated with thrombosis. Laboratory assessment. Clin Lab Med 15:125-163
7. Breit R (1984) Lower leg ulcers in Klinefelter's syndrome. In: Bandmann HJR, Breit R (eds) Klinefelter's syndrome. Springer, Berlin Heidelberg New York Tokyo, pp 71-79
8. Clouse LH, Comp PC (1986) The regulation of hemostasis: the protein C system. N Engl J Med 314:1298-1304
9. Comp PC, Nixon RR, Cooper MR, Esmon CT (1984) Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082-2088
10. Cooper DN, Tuddenham EGD (1994) Molecular genetics of familial venous thrombosis. Br Med Bull 50:833-850
11. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Prediction of a cofactor to activated protein C. Proc Natl Acad Sci 90:1004-1008
12. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH (1988) The frequency of type I heterozygotic protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 59:18-22
13. Griffin JH, Evatt B, Wideman C, Fernandez JA (1993) Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 82:1989-1993
14. Hach-Wunderle V, Scharrer I (1993) Prävalenz des hereditären Mangels an Antithrombin III, Protein C und Protein S. Dtsch Med Wochenschr 118:187-190
15. Harenberg J (1994) Thromboembolieprophylaxe bei erblicher Disposition. Dtsch Arztebl 91:B-1458-1461
16. Justus B, Siegert G, Tiebel O (1992) Veränderungen im Gerinnungs- und Fibrinolysesystem während des Verlaufs der normalen Schwangerschaft. Zentralbl Gynakol 114.165-170
17. Jockenhövel F, Reinwein D (1992) Klinefelter-Syndrom. Dtsch Med Wochenschr 117:383-389
18. Key NS (1995) Toward an understanding of the pathophysiologic mechanism of thrombosis in the antiphospholipid antibody syndrome. Lab Clin Med 125:16-17
19. Koster K, Roosendal FR, de Ronde H, Briet E, Vandenbroueck JP, Bertina RM (1993) Venous thrombosis due to poor anticoagulant response to activated proten C: Leiden Thrombophilia Study. Lancet 342:1503-1506
20. Martinez HR, Rangel-Guerra A, Marfil LJ (1993) Ischemic stroke due to deficiency of coagulation inhibitors. Stroke 24:19-25
21. Robinson K, Mayer E, Jacobsen DW (1994) Homocysteine and coronary artery disease. Clev Clin J Med 61:438-450
22. Samama MH, Horellou MH, Soria J, Conrad J, Nicolas G (1984) Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemost 51:132-133
23. Scharf RE, Harbrecht U (1994) Resistenz gegenüber aktiviertem Protein C Dtsch Med Wochenschr 119:1680-1681
24. Schienle HW, Seitz R, Rohner I, Lerch L, Krumpholz B, Krauss G, Fowler B, Baumgartner R, Willenbockel U, Egbrink R (1994) Coagulation factors and markers of activation of coagulation in homocystinuria (HOCY): a study of two siblings. Blood Coagul Fibrinolysis 5:873-878
25. Schmidtke J (1993) Erbliche Dispositionen zu thrombotischen Erkrankungen. Dtsch Ärztebl 90:B-2271
26. Shigekiyo T, Tomonari A, Uno Y, Kishi Y (1992) Danazol therapy in hypoplasminogenemia. Thromb Haemost 68:233-234
27. Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR (1984) Severe homozygous protein C deficiency. J Pediatr 105:409-413
28. Svensson PJ, Dahlbeck B (1994) Resistance to activated protein C as a basis for venous thrombosis. N Engi J Med 330:517-522
29. Szucs T, Osterkorn D, Schramm W (1996) Gesundheitsökonomische Evaluation des Screenings auf APC Resistenz (Mutation Leiden) bei Neuanwenderinnen von Ovulationshemmern. Med Klin 91:317-319
30. Virchow R (1856) Phlogose und Thrombose. In: Virchow R (Hrsg) Gesammelte Abhandlungen zur Wissenschaftlichen Medizin. Van Meidlinger & Sohn, Frankfurt, S 458-636
31. Wankmuller H, Schwender S, Keller F (1996) APC Resistenz: Pathogenese, Diagnostik, Prävalenz und Bedeutung eines neuen Thromboserisikofaktors. Med Klin 91:308-312
32. Weisendorf DJ, Edson JR (1991) Recurrent venous thrombosis associated with inherited deficiency of heparin cofactor II. Br J Haematol 77:125-126